Surgical excision margins for primary cutaneous melanoma: a Cochrane review - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

Surgical excision margins for primary cutaneous melanoma: a Cochrane review

Description:

Source: Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis ... Patients diagnosed with in-situ melanoma (Stage 0) were not eligible. ... – PowerPoint PPT presentation

Number of Views:92
Avg rating:3.0/5.0
Slides: 12
Provided by: MikeC161
Category:

less

Transcript and Presenter's Notes

Title: Surgical excision margins for primary cutaneous melanoma: a Cochrane review


1
Surgical excision margins for primary cutaneous
melanoma a Cochrane review
  • Clinical

2
Clinical question
  • Does the width of the excision margins influence
    survival following surgery for primary cutaneous
    melanoma?

Source Sladden MJ, Balch C, Barzilai DA, Berg D,
Freiman A, Handiside T, Hollis S, Lens MB,
Thompson JF. Surgical excision margins for
primary cutaneous melanoma. Cochrane Database of
Systematic Reviews 2009, Issue 4. Art. No.
CD004835. DOI 10.1002/14651858.CD004835.pub2.
3
Context
  • Cutaneous melanoma accounts for 5 of skin
    cancers, but 75 of skin cancer deaths.
  • Primary cutaneous melanoma is confined to the
    skin, with no evidence of spread elsewhere in the
    body.
  • The only potentially curative treatment currently
    available is surgery.
  • National guidelines provide some consistent
    generalisations regarding the width of excision
    margins, but offer slightly different advice.

4
Current national guidelines for excision margins
for primary cutaneous melanoma
Breslow Thickness UK (2002) US (2009) Australian (2008) Swiss (2005) Dutch (2005) German (2008)
In-situ 2 to 5 mm 5 mm 5 mm 5 mm 5 mm 5 mm
1 mm 1 cm 1 cm 1 cm 1 cm 1 cm 1 cm
1.01 to 2 mm 1 to 2 cm 1 to 2 cm 1 to 2 cm 1 cm 1 cm 1 cm
2.01 to 4 mm 2 to 3 cm 2 cm 1 to 2 cm 2 cm 2 cm 2 cm
gt 4 mm 2 to 3 cm 2 cm 2 cm 2 cm 2 cm 2 cm
Margins may be modified to accommodate
individual anatomic or functional
considerations. Caution be exercised for
melanomas 2 to 4 mm thick, because evidence
concerning optimal excision margins is unclear.
Where possible, it may be desirable to take a
wider margin (2 cm) for these tumours depending
on tumour site and surgeon/patient preference.
www.cochranejournalclub.com
5
Methods
  • A Cochrane intervention review.
  • Authors searched for eligible studies in the
    Cochrane Skin Group register, The Cochrane
    Central Register of Controlled Trials, MEDLINE
    and EMBASE up to August 2009.
  • Hazard ratios (HR) were used for the primary
    analyses, summarising the average effect over 5
    and 10 years of follow up.
  • Planned subgroup analysis by site of the melanoma
    and its thickness were not possible because of
    insufficient data.

6
PICO(S) to assess eligible studies
  • Participants All ages and all ethnic groups with
    primary cutaneous melanoma, of all Breslow
    thicknesses, confirmed histologically on biopsy
    and without metastases (AJCC/UICC Stage I and
    II). Patients diagnosed with in-situ melanoma
    (Stage 0) were not eligible.
  • Intervention and Comparison Different widths of
    excision margins. Narrow and wide margins were
    not pre-defined.
  • Outcomes include
  • Time to death, and time to death or recurrence
  • Quality of life
  • Adverse effects (including surgical
    complications)
  • Studies Randomized controlled trials.

7
Description of eligible studies
  • Five randomised controlled trials (RCTs),
    published in 11 reports, testing three different
    comparisons of excision margins
  • 1 cm versus 3 cm (2 RCTs, 1603 participants)
  • 2 cm versus 4 cm (1 RCT, 486 participants)
  • 2 cm versus 5 cm (2 RCTs, 1326 participants)
  • All trials reported analyses of death and
    recurrence, one trial reported on quality of life
    and two trials reported on adverse events.

8
Results Deaths and recurrence
  • Deaths from any cause
  • Hazard Ratio for all deaths was non-significantly
    in favour of wider excision (1.04, 95 confidence
    interval 0.95 to 1.15).
  • This is compatible with between about 6 fewer
    deaths per 1000 patients over ten years after
    narrow excision and 18 fewer deaths per 1000
    after wider excision.
  • Recurrence or deaths from any cause
  • Hazard ratio for recurrence or death was
    non-significantly in favour of wider excision
    (1.13, 95 confidence interval 0.99 to 1.28).

9
Results Quality of life and adverse events
  • Quality of life
  • Patients treated with a 3 cm margin had
    significantly poorer physical and mental function
    than those in the 1 cm group one month after
    surgery. This difference was not apparent by six
    months.
  • Those treated with a 3 cm margin had a poorer
    perception of their scar than those treated with
    a 1 cm margin.
  • Adverse effects
  • Skin grafts were reduced from 46 with 4 cm
    margins to 11 with 2 cm margins. This led to
    hospital stays that were shorter by 1 or 2 days.
  • There was no significant difference in wound
    infection.

10
Results Deaths from any cause
11
Useful links
  • Surgical excision margins for primary cutaneous
    melanoma (the Cochrane Review)
  • Cochrane Journal Club discussion points
  • Cochrane Handbook for Systematic Reviews of
    Interventions
  • Chapter 7.7.6  Data extraction for time-to-event
    outcomes
  • Chapter 9.2.6  Effect measures for time-to-event
    (survival) outcomes
  • ParmarMK, Torri V, Stewart L. Extracting summary
    statistics to perform meta-analyses of the
    published literature for survival endpoints.
    Statistics in Medicine 199817(24)281534.
  • Williamson PR, Smith CT, Hutton JL, Marson AG.
    Aggregate data meta-analysis with time-to-event
    outcomes. Statistics in Medicine
    200221(22)333751
Write a Comment
User Comments (0)
About PowerShow.com